Revna Biosciences, a Tekedia Capital portfolio, will improve patient healthcare with Precision Medicine in Africa

Precision medicine or personalized medicine is a cutting-edge innovation in healthcare delivery. It facilitates highly accurate detection, prevention, and treatment of diseases by considering each individual’s genetic makeup, lifestyle, ethnicity, family history, behavior, and environment. Currently, patients requiring blood transfusion are matched to blood samples of individuals with identical blood groups, which minimizes potential side … Continue reading Revna Biosciences, a Tekedia Capital portfolio, will improve patient healthcare with Precision Medicine in Africa